Patients can now easily buy these tests, but cardiologists must consider their quality when using the information to guide ...

Q4 2024 Earnings Call Transcript March 12, 2025 OptimizeRx Corporation beats earnings expectations. Reported EPS is $0.3, ...

OptimizeRx Corp (OPRX) reports a 14% increase in fourth-quarter revenue and significant gross margin improvement, while transitioning to a subscription-based model for enhanced predictability.

Stephen Silvestro; President, Chief Executive Officer; OPTIMIZERx Corp. Edward Stelmakh; Chief Financial Officer, Chief Operating Officer; OPTIMIZERx Corp. Andrew D' ...

Q4 revenue of $32.3 million, increasing 14% year-over-yearQ4 gross profit increased 23% year-over-year to $22.0 million with gross margin of 68%Company generated revenue from 48 DAAP deals in 2024, up ...

Q4 revenue of $32.3 million, increasing 14% year-over-yearQ4 gross profit increased 23% year-over-year to $22.0 million with gross margin of ...

The OptimizeRx Board of Directors will make its formal recommendation regarding director nominations in the Company’s definitive proxy statement which will be filed with the Securities and Exchange ...

In 2024, the global cosmetic dropper market generated revenue of USD 91.1 million, and this figure is projected to reach USD ...

ZoomRx has dug into its data to see what messages resonate with healthcare professionals (HCPs) at different stages | ZoomRx ...

Using MRI for healthy controls from the HCP, nine GM patterns identified from patients with SPMS were uniquely correlated and present also in healthy controls, suggesting that they are not disease ...

The new ‘UK Hub for One Health Systems: Creating Sustainable Health and Social Care Pathways’ brings together a range of university and healthcare partners throughout the UK, to tackle the challenge ...

Molecular Partners will present at TD Cowen and Leerink healthcare conferences and host a financial results call on March 7. Molecular Partners AG, a clinical-stage biotech company focused on ...